Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment

Brain Research

Volumn 734, Issue 1-2, 1996, Pages 35-42

  Gnegy, M E ^a   Hewlett, G H K ^a   Pimputkar, Gouri ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Amphetamine sensitization; Caldesmon; Calmodulin binding protein; Dopamine receptor; Glutamate; N Methyl D aspartate (NMDA) receptor

Indexed keywords

AMPHETAMINE; CALMODULIN; DIZOCILPINE; DOPAMINE RECEPTOR; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030599214     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00293-4     Document Type: Article

References (63)

1. 3H-SCH 23390 binding in rat striatum, Life Sci., 37 (1985) 1971-1983.
2. [2] Antelman, S.M., Kocan, D., Knopf, S., Edwards, D.J. and Caggiula, A.R., One brief exposure to a psychological Stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol, Life Sci., 51 (1992) 261-266.
3. [3] Benes, F.M., Paskevich, P.A., Davidson, J. and Domesick, V.B., The effects of haloperidol on synaptic patterns in the rat striatum, Brain Res., 329 (1985) 265-274.
4. [4] Billingsley, M.L., Pennypacker, K.R., Hoover, C.G., Brigati, D.J. and Kincaid, R.L., A rapid and sensitive method for detection and quantification of calcineurin and calmodulin-binding proteins using biotinylated calmodulin, Proc. Natl. Acad. Sci. USA, 82 (1985) 7585-7589.
5. [5] Burgoyne, R.D., Cheek, T.R. and Norman, K.M., Identification of a secretory granule-binding protein as caldesmon, Nature, 319 (1986) 68-70.
6. [6] Carey, R.J. and DeVeaugh-Geiss, J., Treatment schedule as a determinant of the development of tolerance to haloperidol, Psychopharmacology (Berl.), 82 (1984) 164-167.
7. [7] Castañeda, E., Becker, J.B. and Robinson, T.E., The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro, Life Sci., 42 (1988) 2447-2456.
8. [8] Chamberlain, L.H., Roth, D., Morgan, A. and Burgoyne, R.D., Distinct effects of α-SNAP, 14-3-3 proteins, and calmodulin on priming and triggering of regulated exocytosis, J. Cell Biol., 130 (1995) 1063-1070.
9. [9] Creese, I. and Iversen, S.D., The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat, Psychopharmacologia, 39 (1974) 345-357.
10. [10] Davis, J.M. and Schlemmer, R.F., The amphetamine psychosis. In J. Caldwell (Ed.), Amphetamines and Related Stimulants, CRC Press, Boca Raton, FL, 1980, pp. 161-173.
11. [11] De Camilli, P., Benfenati, F., Valtorta, F. and Greengard, P., The synapsins, Annu. Rev. Cell Biol., 6 (1990) 433-460.
12. 2+ binding, conformational changes, and phosphodiesterase activity. J. Biol. Chem., 252 (1977) 8415-8422.
13. [13] Ellinwood, E.H., Amphetamine psychosis: individuals, settings, and sequences. In E.H. Ellinwood and S. Cohen (Eds.), Current Concepts on Amphetamine Abuse, US Government Printing Office, Washington, DC, 1972, pp. 143-157.
14. [14] Fifkova, E. and Morales, M., Calcium-regulated contractile and cytoskeletal proteins in dendritic spines may control synaptic plasticity, Ann. NY Acad. Sci., 568 (1989) 131-137.
15. 2+-binding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors, J. Pharmacol. Exp. Ther., 202 (1977) 558-564.
16. [16] Gnegy, M.E., Agrawal, A., Hewlett, K., Yeung, E. and Yee, S., Repeated haloperidol increases both calmodulin and a calmodulin-binding protein in rat striatum, Mol. Brain Res., 27 (1994) 195-204.
17. [17] Gnegy, M.E., Hewlett, G.H.K., Yee, S.L. and Welsh, M.J., Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine, Brain Res., 562 (1991) 6-12.
18. 2+ regulated protein activator of cAMP phosphodiesterase, Naunyn. Schmiedeberg's Arch. Pharmacol., 301 (1977) 121-127.
19. [19] Hanbauer, I., Pradham, S. and Yang, H.-Y.T., Role of calmodulin in dopaminergic transmission, Ann. NY Acad. Sci., 356 (1980) 292-303.
20. [20] Hayashi, T., Tadokoro, S., Hashimoto, H. and Nakashima, M., Enhancement of avoidance-suppressing effect after repeated administration of haloperidol and serum haloperidol in rats, Pharmacol. Biochem. Behav., 17 (1982) 131-136.
21. [21] Heffner, T.G., Hartman, J.A. and Seiden, L.S., A rapid method for the regional dissection of the rat brain, Pharmacol. Biochem. Behav., 13 (1980) 453-456.
22. [22] Hegmann, T.E., Lin, J.L. and Lin, J.J., Probing the role of nonmuscle tropomyosin isoforms in intracellular granule movement by microinjection of monoclonal antibodies, J. Cell Biol., 109 (1989) 1141-1152.
23. [23] Hegmann, T.E., Schulte, D.L., Lin, J.L. and Lin, J.J., Inhibition of intracellular granule movement by microinjection of monoclonal antibodies against caldesmon, Cell Motil. Cytoskeleton, 20 (1991) 109-120.
24. 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro, Life Sci., 23 (1978) 551-555.
25. [25] Janovick, J.A., Natarajan, K., Longo, F. and Conn, P.M., Caldesmon: a bifunctional (calmodulin and actin) binding protein which regulates stimulated gonadotropin release, Endocrinology, 129 (1991) 68-74.
26. 1 receptors modulate glutamate transmission in the ventral tegmental area, J. Neurosci., 15 (1995) 5379-5388.
27. [27] Kalivas, P.W. and Weber, B., Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine, J. Pharmacol. Exp. Ther., 245 (1988) 1095-1102.
28. [28] Karler, R., Calder, L.D., Chaudhry, I.A. and Turkanis, S.A., Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801, Life Sci., 45 (1989) 599-606.
29. [29] Karler, R., Calder, L.D. and Turkanis, S.A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552 (1991) 295-300.
30. [30] Karler, R., Chaudhry, I.A., Calder, L.D. and Turkanis, S.A., Amphetamine behavioral sensitization and the excitatory amino acids, Brain Res., 537 (1990) 76-82.
31. [31] Kelly, P.H., Seviour, P.W. and Iversen, S.D., Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res., 94 (1975) 507-522.
32. [32] Klintzova, A.J., Haselhorst, U., Uranova, N.A., Schenk, H. and Istomin, V.V., The effects of haloperidol on synaptic plasticity in rat's medial prefrontal cortex, J. Hirnforsch., 30 (1989) 51-57.
33. [33] Kolta, M.B., Shreve, P., De Souza, V. and Uretsky, N.J., Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine, Neuropharmacology, 24 (1985) 823-829.
34. [34] Kolta, M.G., Shreve, P. and Uretsky, N.J., Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens, Neuropharmacology, 28 (1989) 9-14.
35. [35] Kuczenski, R. and Leith, N.J., Chronic amphetamine: Is dopamine a link in or mediator of the development of tolerance and reverse tolerance? Pharmacol. Biochem. Behav., 15 (1981) 405-413.
36. [36] Kuribara, H., Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol, Psychopharmacology (Berl.), 119 (1995) 34-38.
37. [37] Kuribara, H. and Tadokoro, S., Enhancement of the avoidance-suppressing effects of neuroleptic agents after repeated administration: changes in the discriminated avoidance response in rats, Psychopharmacology (Berl.), 75 (1981) 148-151.
38. [38] Liu, J.-P., Sim, A.T.R. and Robinson, P.J., Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization, Science, 265 (1994) 970-973.
39. 2+-dependent regulator protein and dopaminergic receptor function, Brain Res., 155 (1978) 130-135.
40. [40] Lynch, G. and Baudry, M., Brain spectrin, calpain and long-term changes in synaptic efficacy, Brain Res. Bull., 18 (1987) 809-815.
41. [41] Masuda, Y., Murai, S. and Itoh, T., Tolerance and reverse tolerance to haloperidol catalepsy induced by the difference of administration interval in mice, Jpn. J. Pharmacol., 32 (1982) 1186-1188.
42. [42] Matsumura, F. and Yamashiro, S., Caldesmon, Curr. Opin. Cell Biol., 5 (1993) 70-76.
43. [43] Matthies, H.J.G., Miller, R.J. and Palfrey, H.C., Calmodulin binding to and cAMP-dependent phosphorylation of kinesin light chains modulate kinesin ATPase activity, J. Biol. Chem., 268 (1993) 11176-11187.
44. [44] Paulson, P.E., Camp, D.M. and Robinson, T.E., The time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats, Psychopharmacology, 103 (1991) 480-492.
45. [45] Paulson, P.E. and Robinson, T.E., Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats, Synapse, 19 (1995) 56-65.
46. [46] Pieribone, V.A., Shupliakov, O., Brodin, L., Hilfiker-Rothenfluh, S., Czernik, A.J. and Greengard, P., Distinct pools of synaptic vesicles in neurotransmitter release, Nature, 375 (1995) 493-497.
47. [47] Popov, N. and Matthies, H., Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions, Eur. J. Pharmacol., 172 (1989) 205-210.
48. [48] Popov, N., Schulzeck, S., Nuss, D., Vopel, A.-U., Jendrny, C., Struy, H. and Matthies, H., Alterations in calmodulin content of rat brain areas after chronic application of haloperidol and amphetamine, Biochem. Biochim. Acta, 47 (1988) 435-441.
49. [49] Roberts-Lewis, J.M., Welsh, M.J. and Gnegy, M.E., Chronic amphetamine treatment increases striatal calmodulin in rats, Brain Res., 384 (1986) 383-386.
50. [50] Robinson, T.E., Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats, Psychopharmacology, 84 (1984) 466-475.
51. [51] Robinson, T.E., The neurobiology of amphetamine psychosis: evidence from studies with an animal model. In T. Nakazawa (Ed.), Taniguchi Symposia on Brain Sciences, Vol. 14, Biological Basis of Schizophrenic Disorders, Japan Scientific Societies Press, Tokyo, 1991, pp. 185-201.
52. [52] Robinson, T.E. and Becker, J.B., Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro, Eur. J. Pharmacol., 85 (1982) 253-254.
53. [53] Robinson, T.E. and Becker, J.B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Res. Rev., 11 (1986) 157-198.
54. [54] Roseboom, P.H., Hewlett, G.H.K. and Gnegy, M.E., Repeated amphetamine administration alters the interaction between DI-stimulated adenylyl cyclase activity and calmodulin in rat striatum, J. Pharmacol. Exp. Ther., 255 (1990) 197-203.
55. [55] Sato, M., Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity - a clinical survey. Psychopharmacol. Bull., 22 (1986) 750-756.
56. [56] Sato, M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis, Ann. NY Acad. Sci., 654 (1992) 160-170.
57. [57] Stewart, J. and Vezina, P., Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine, Brain Res., 495 (1989) 401-406.
58. [58] Sweet, S.C., Gnegy, M.E. and Welsh, M.J., A method for the removal of affinity-matrix specific antibody from antigen affinity-purified polyclonal antibodies to calmodulin, J. Immunol. Methods, 36 (1991) 31-36.
59. [59] Uranova, N.A., Klintzova, A.J., Istomin, V.V., Haselhorst, U. and Schenk, H., The effects of amphetamine on synaptic plasticity in rat's medial prefrontal cortex, J. Hirnforsch., 30 (1989) 45-50.
60. [60] Vezina, P. and Stewart, J., The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine, Brain Res., 499 (1989) 108-120.
61. [61] Vezina, P. and Stewart, J., Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects, Brain Res., 516 (1990) 99-106.
62. [62] Wolf, M.E. and Khansa, M.R., Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine, Brain Res., 562 (1991) 164-168.
63. [63] Wolf, M.E., White, F.J., Nassar, R., Brooderson, R.J. and Khansa, M.R., Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization, J. Pharmacol. Exp. Ther., 264 (1993) 249-255.